Skip to content
In stock Zantac
Acid Reflux

Zantac

By reducing stomach-acid activity, Zantac tablets are intended to ease acid-related gastrointestinal symptoms. They are used in clinical care for problems such as heartburn and ulcer-related…

Guaranteed quality Original product
Delivery: from 4 days Discreet shipping
24/7 Support Always available
Active ingredient: Ranitidine
Select dosage:
Select pack Package Per unit Price
$ 1.92 $ 230.01
$ 1.63 $ 345.02 $ 293.59 Save 15%
Free Regular Delivery $ 1.42 $ 517.52 $ 383.35 Save 26%
Best value Free Regular Delivery $ 1.30 $ 690.03 $ 467.50 Save 32%
$ 0.87 $ 78.54
$ 0.73 $ 104.72 $ 87.89 Save 16%
$ 0.56 $ 157.08 $ 100.98 Save 36%
$ 0.46 $ 235.62 $ 123.42 Save 48%
Best value $ 0.40 $ 314.16 $ 143.99 Save 54%

Free delivery on orders from $ 374.00, free express delivery from $ 561.00

Secure payment methods:
VISA AMEX JCB DISCOVER

By reducing stomach-acid activity, Zantac tablets are intended to ease acid-related gastrointestinal symptoms. They are used in clinical care for problems such as heartburn and ulcer-related discomfort when the formulation and active ingredient are appropriate for the patient.

Product information

Zantac is associated with acid-suppression treatment for heartburn and other acid-related gastrointestinal conditions. Historical Zantac products contained ranitidine, an H2-receptor antagonist that reduced acid secretion by blocking histamine signals in the stomach. The exact active ingredient and strength must match the specific formulation supplied for treatment.

Directions for use

Zantac tablets are taken by mouth. Dosing differs between strengths and between users, so there is no single amount that suits everyone.

A prescribing clinician determines:

  • the tablet strength;
  • the number of doses each day;
  • whether treatment is needed before meals, after meals, or at bedtime;
  • the duration of treatment;
  • whether kidney or liver function requires a change in dosing.

Some acid-related symptoms respond to treatment taken at a regular time, while others require administration around a predictable trigger such as an evening meal. The timing depends on the formulation and the condition being treated. A clinician or authorised prescriber selects the regimen rather than using a standard amount for every adult.

Swallow tablets with water unless the product-specific instructions state otherwise. Do not crush, split, or chew a tablet unless the supplied formulation is designed for that method. Altering a tablet can change how the dose is released or absorbed.

If a dose is missed, take it when remembered unless the next scheduled dose is close. Skipping the missed dose is safer than taking two doses together. Accidental double dosing can increase adverse effects without providing faster symptom relief.

A prescription doctor may dispense or authorise Zantac when acid suppression is clinically suitable. Medsafe regulates medicines supplied in New Zealand and provides safety information for healthcare professionals and consumers [2].

Ingredients

Zantac is associated with acid-suppression treatment for heartburn and other acid-related gastrointestinal conditions. Historical Zantac products contained ranitidine, an H2-receptor antagonist that reduced acid secretion by blocking histamine signals in the stomach. The exact active ingredient and strength must match the specific formulation supplied for treatment.

H2 blockers act on histamine-2 receptors in stomach cells. Blocking these receptors reduces the volume of acid released into the stomach, which can relieve burning discomfort and support healing in some ulcer conditions. The FDA described ranitidine’s pharmacological action and clinical uses in its prescribing information [1].

Acid suppression can reduce symptoms without removing the underlying cause of reflux, ulcer disease, or persistent stomach pain. Recurrent symptoms, vomiting, black stools, unexplained weight loss, or difficulty swallowing require prompt medical assessment because acid treatment alone may delay investigation of a more serious condition.

Do not assume that two products carrying the Zantac name have identical strengths or active ingredients. The dosing decision must be based on the formulation supplied and the patient’s clinical circumstances.

How it affects the body

H2 blockers act on histamine-2 receptors in stomach cells. Blocking these receptors reduces the volume of acid released into the stomach, which can relieve burning discomfort and support healing in some ulcer conditions. The FDA described ranitidine’s pharmacological action and clinical uses in its prescribing information [1].

Therapeutic indications

Zantac is associated with acid-suppression treatment for heartburn and other acid-related gastrointestinal conditions. It may be used for ulcer-related discomfort when the specific formulation and active ingredient are appropriate for the patient. The exact product strength and treatment plan must be determined for the individual.

Common mistakes

Several habits make acid-related treatment less useful:

  • taking an extra tablet because symptoms have not eased immediately;
  • combining several acid remedies without recording their ingredients;
  • crushing a tablet without confirming that it can be altered;
  • using paracetamol-containing cold remedies alongside separate paracetamol;
  • continuing treatment for weeks while ignoring bleeding, weight loss, or swallowing problems;
  • stopping a regular regimen abruptly without understanding the treatment plan;
  • assuming stomach pain always comes from excess acid;
  • forgetting to mention kidney disease or prescribed medicines.

One mistake occurs at night. A patient may take a second dose after waking with burning, even though the first dose is still active. The safer response depends on the prescribed schedule and the time remaining before the next dose.

Another is using anti-inflammatory painkillers for stomach pain. Medicines such as ibuprofen can irritate the stomach and increase ulcer or bleeding risk in susceptible people. Paracetamol has a different risk profile, but its total daily amount still matters.

Reasons not to use it

  • previous allergy to the active ingredient or another component;
  • unexplained gastrointestinal bleeding;
  • black, tarry stools or vomiting blood;
  • difficulty swallowing;
  • unexplained weight loss;
  • severe or persistent abdominal pain;
  • significant kidney impairment;
  • significant liver disease;
  • a history of medicine-related heart-rhythm problems;
  • pregnancy or breastfeeding without a clear clinical reason;
  • use of medicines with a clinically important interaction.

When this is not for you

Zantac treatment is not suitable for everyone. It is not for you if you have warning symptoms, a relevant allergy, or an interaction risk that requires clinical review. People with reduced kidney function may need a lower dose or a longer interval between doses, depending on the active ingredient. Older adults may be more sensitive to confusion, dizziness, and rhythm disturbances.

Red-flag symptoms should not be masked by repeated self-treatment. Night-time pain, recurrent vomiting, anaemia, or symptoms beginning later in life can require testing for ulcer disease, reflux complications, infection, or malignancy.

Unwanted effects

Acid-suppressing treatment can cause unwanted effects even when taken at the recommended dose. Reported reactions associated with ranitidine products included constipation, nausea, stomach pain, headache, dizziness, and skin rash.

Common or less serious effects may include:

  • constipation or looser stools;
  • nausea;
  • abdominal discomfort or stomach pain;
  • headache;
  • dizziness;
  • tiredness;
  • a mild skin rash.

A rash deserves attention if it spreads, becomes painful, blisters, or occurs with facial swelling or breathing difficulty. Those symptoms may indicate a serious allergic reaction and require urgent medical care.

Rare reactions reported with H2-blocker treatment included confusion, changes in heart rhythm, liver inflammation, and blood-count abnormalities. The risk may be higher in older adults or people with impaired kidney or liver function. The FDA prescribing information lists these clinically significant reactions and the circumstances requiring caution .

One practical detail is easy to miss: stomach pain that continues despite acid suppression is not automatically evidence that the dose is too low. Persistent pain may reflect infection, gallbladder disease, ulcer complications, or another gastrointestinal condition.

Keep a short record of new symptoms after treatment begins. The timing helps distinguish a medicine-related reaction from symptoms caused by the underlying digestive condition.

Comparison

Alternative treatment depends on the diagnosis, symptom pattern, medicine history, and risk factors. It is better to compare pharmacological classes than to select an alternative by brand name.

Treatment category Main action Typical clinical role
H2 blocker Reduces histamine-driven acid secretion Intermittent or regular acid suppression
Proton pump inhibitor Blocks the final acid-secretion pathway Stronger or longer-lasting suppression for selected conditions
Alginate or antacid Acts locally on acid or refluxed stomach contents Short-term symptom relief

Famotidine is another H2 blocker. Omeprazole, pantoprazole, esomeprazole, and lansoprazole are proton pump inhibitors. These medicines are not interchangeable tablet-for-tablet because their pharmacology, dosing schedules, interactions, and approved uses differ.

Proton pump inhibitors often provide stronger acid suppression for confirmed reflux disease, erosive oesophagitis, or ulcer treatment. An H2 blocker may suit a different clinical pattern, such as selected intermittent symptoms or situations where a prescriber wants a different mechanism. The European Medicines Agency describes acid-suppression medicines according to their active substances, indications, and safety profiles rather than treating the whole class as interchangeable [3].

What doctors say

In clinical practice, doctors generally separate symptom relief from diagnosis. A patient may feel better within a short period, yet the cause of repeated heartburn can remain untreated. Treatment choice is stronger when the clinician knows how often symptoms occur, whether they follow meals, and whether they wake the patient at night.

A prescriber also considers previous treatment response. Failure after one or two doses does not always mean that acid suppression has failed, while repeated treatment without improvement should prompt reassessment. The dose should not be increased independently.

Another practical point concerns stopping regular therapy. Some patients experience a return of burning symptoms after stopping prolonged acid suppression. The response can reflect rebound acid secretion or recurrence of the original condition, and the management plan may need adjustment.

Medsafe’s medicine-safety framework supports risk-based prescribing, especially where age, organ impairment, interactions, and treatment duration affect the balance between benefit and harm .

What customers often ask

Do you offer anonymous delivery?

Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.

Comparison

Dexilant

Active ingredient: Dexlansoprazole
30mg 60mg
From $ 203.83
pills
4.1 (4)

Pariet

Active ingredient: Rabeprazole
20mg
From $ 173.91
pills
3.9 (4)

Zantac Current

Active ingredient: Ranitidine
300mg 150mg
From $ 78.54
pills
3.8 (5)

How the medicines for Acid Reflux compare

Long-term acid suppression

Long-term acid suppression should have a defined clinical reason. Possible concerns include nutrient malabsorption, gastrointestinal infections, and changes in bone or kidney health in susceptible patients. These risks depend on the medicine, dose, duration, and patient characteristics.

How Buyers Rate Zantac

Based on 5 reviews

Christopher, 64 Verified
Rating: 4 out of 5

The burning settled after I followed the prescribed routine. I still had to change late meals because the tablet did not make every trigger disappear.

Te Awamutu Over a short course 20 Nov 2026
Alison, 69 Verified
Rating: 3.5 out of 5

The nausea was mild but noticeable at first. I stopped taking extra over-the-counter remedies at the same time and found the symptoms easier to track.

Gisborne Several days 23 Oct 2026
Stephen D., 38 Verified
Rating: 4 out of 5

The tablets helped the night symptoms, although the first improvement was slower than I expected. My doctor reviewed the treatment when the discomfort returned.

Timaru Two weeks 30 Oct 2026
Helen Z., 34 Verified
Rating: 5 out of 5

Heartburn was less frequent during the course. I still experienced stomach discomfort after a very late meal, so I did not treat the medicine as permission to ignore food triggers.

Ashburton A treatment course 9 Nov 2026
Neil C., 59 Verified
Rating: 2.5 out of 5

The treatment did not resolve ongoing abdominal pain. Further assessment was needed, and increasing the dose myself would have been the wrong approach.

Hamilton The treatment course 16 Nov 2026

Sources

  1. U.S. Food and Drug Administration (2019). Zantac (ranitidine hydrochloride) tablets: prescribing information.
  2. Medsafe (2023). Medicine safety information and consumer medicine information resources.
  3. European Medicines Agency (2020). Ranitidine-containing medicinal products: referral and safety information.
Get our free app Shop faster and track your orders 3.9 · 467 reviews Install